These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25811161)

  • 1. Subjective and Objective Measures in the Treatment of Hemifacial Spasm With OnabotulinumtoxinA.
    Chundury RV; D'Angelo AS; Couch SM; Holds JB
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):133-7. PubMed ID: 25811161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox).
    Couch SM; Chundury RV; Holds JB
    Ophthalmic Plast Reconstr Surg; 2014; 30(3):246-50. PubMed ID: 24807539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
    Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
    Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Corneal Parameters Between Affected and Normal Contralateral Eyes in Patients With Hemifacial Spasm Treated With Botulinum Toxin-A: Outcomes During One Complete Treatment Cycle.
    Osaki T; Osaki MH; Osaki TH; Hirai FE; Campos M
    Cornea; 2016 Feb; 35(2):220-5. PubMed ID: 26619386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry.
    Xiao L; Pan L; Li B; Zhou Y; Pan Y; Zhang X; Hu Y; Dressler D; Jin L
    J Neurol; 2018 Sep; 265(9):2097-2105. PubMed ID: 29987587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target.
    Wei LA; Diels J; Lucarelli MJ
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platysma synkinesis in facial palsy and botulinum toxin type A.
    Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
    Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synkinesis in primary and postparalytic hemifacial spasm: Clinical features and therapeutic outcomes of botulinum toxin A treatment.
    Su JH; Yang MN; Teng F; Zhang XL; Pan YG; Hu Y; Xiao LB; Pan LZ; Li LX; Jin LJ
    Toxicon; 2020 Sep; 184():122-126. PubMed ID: 32553733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A.
    Kongsaengdao S; Maneeton N; Maneeton B
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33809486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
    Kongsengdao S; Kritalukkul S
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facial spasms.
    Blitzer AL; Phelps PO
    Dis Mon; 2020 Oct; 66(10):101041. PubMed ID: 32622683
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis: A Randomized Clinical Trial.
    Thomas AJ; Larson MO; Braden S; Cannon RB; Ward PD
    JAMA Facial Plast Surg; 2018 Mar; 20(2):141-147. PubMed ID: 28973094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis.
    Filipo R; Spahiu I; Covelli E; Nicastri M; Bertoli GA
    Laryngoscope; 2012 Feb; 122(2):266-70. PubMed ID: 22252570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A is effective to treat tension-type headache caused by hemifacial spasm.
    Mizuma A; Nagata E; Yasuda T; Kouchi M; Nakayama T; Honma K; Tokuoka K; Kitagawa Y; Nogawa S; Takizawa S
    J Clin Neurosci; 2017 Oct; 44():284-288. PubMed ID: 28734794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment.
    Jog M; Wein T; Bhogal M; Dhani S; Miller R; Ismail F; Beauchamp R; Trentin G
    Can J Neurol Sci; 2016 Sep; 43(5):687-96. PubMed ID: 27430524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
    Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the Jankovic-assessment be used as an alternative to electromyography? A cross-sectional study on facial dystonia patients treated with Botulinum toxin.
    Di Stadio A; Dipietro L; Gambacorta V; Cristi MC; Faralli M; Della Volpe A; Ricci G
    Am J Otolaryngol; 2019; 40(6):102278. PubMed ID: 31477366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm.
    Pandey S; Jain S
    Neurol India; 2018; 66(4):1036-1042. PubMed ID: 30038089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
    Wu CJ; Shen JH; Chen Y; Lian YJ
    Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.